Basket (0)
Wishlist (0)
Your personal newsletter
__

 
Product details:
ISBN13:9781032706429
ISBN10:1032706422
Binding:Hardback
No. of pages:262 pages
Size:280x210 mm
Language:English
Illustrations: 1 Illustrations, black & white; 67 Illustrations, color; 1 Halftones, color; 1 Line drawings, black & white; 66 Line drawings, color; 15 Tables, black & white
700
Category:

Exploring the Gut Microbiome in Cancer

From Biomarkers to Personalized Therapies
 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:
Publisher's listprice:
GBP 120.00
Estimated price in HUF:
57 960 HUF (55 200 HUF + 5% VAT)
Why estimated?
 
Your price:
52 164 (49 680 HUF + 5% VAT )
discount is: 10% (approx 5 796 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Not yet published.
 
Add to basket
  Piece(s)

 
Short description:

This book explores the role of the gut microbiome in cancer initiation, progression, and treatment response to present gut microbiome biomarkers for cancer diagnosis and strategies for modulating microbiome for personalized cancer therapies. The work is intended for cancer researchers, medical oncologists, clinicians, and pharmacologists.

Long description:

This book explores the relationship between the gut microbiome and cancer, illuminating various facets from fundamental roles to personalized therapies. It provides a comprehensive overview of the impact of the gut microbiome on cancer development, offering potential for innovative diagnostic and treatment approaches.



  • The book discusses the role of dysbiosis in cancer development, the influence of the microbiome on treatment responses, and strategies to modulate the microbiome for enhanced therapies.

  • It reviews the influence of the gut microbiome on immunotherapy resistance and chemoresistance in cancer patients.

  • Additionally, the book presents gut microbiome biomarkers for cancer diagnosis and prognosis, the implication of the gut-brain axis on cancer development and progression, and the impact of diet and lifestyle on the microbiome.

Towards the end, the book investigates the role of the gut microbiome in pediatric cancer and provides an outlook on the future challenges, technological advancements, and ethical considerations of gut microbiome research in the context of personalized cancer therapies. This book is intended for cancer researchers, medical oncologists, clinicians, pharmacologists, translational investigators, and medical students.



Table of Contents:
Chapter 1. Introduction to the Gut Microbiome and Cancer. Chapter 2. Gut Microbiome Dysbiosis and Cancer Risk. Chapter 3. Gut Microbiome and Cancer Treatment Response. Chapter 4. Gut Microbiome Modulation for Personalized Cancer Therapies. Chapter 5. Gut Microbiome and Immunotherapy Resistance. Chapter 6. Gut Microbiome and Chemotherapy Resistance. Chapter 7. Gut Microbiome Biomarkers for Cancer Diagnosis and Prognosis. Chapter 8. Microbial Metabolites and Cancer. Chapter 9. Gut-Brain Axis and Cancer Delving into the intricate connection between the gut and the brain. Chapter 10. Gut Microbiome and Cancer-Related Inflammation. Chapter 11. Diet, Lifestyle, and the Gut Microbiome. Chapter 12. Gut Microbiome and Pediatric Cancer. Chapter 13. Gut Microbiome and Systemic Side Effects of Cancer Therapies. Chapter 14. Gut Microbiome and Precision Medicine in Cancer. Chapter 15. Therapeutic Potential of the Gut Virome in Cancer. Chapter 16. Microbiome-Based Cancer Therapeutics. Chapter 17. Gut Microbiome Engineering for Cancer Therapies. Chapter 18. Future Perspectives and Challenges in Gut Microbiome Research.